MRI to check Response to chemotherapy in Breast cancer patients
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2021/06/034325
- Lead Sponsor
- Dr Smiti Sripathi Research Award For Breast Imaging Endowment Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with Early breast cancer being treated with Neoadjuvant chemotherapy. Patients diagnosed with Locally advanced breast cancer, being treated with Neoadjuvant chemotherapy. Baseline and mid-cycle MRI (taken after 3 cycles of chemotherapy) to be taken.
Exclusion Criteria
Patients with metastatic carcinoma of breast.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MRI study (DCE/DWI) of breast, taken Mid-cycle of Neoadjuvant chemotherapy, in Breast cancer patients, effectively helps predict complete pathological response after completion of NAC in Breast cancer patients. <br/ ><br>Timepoint: One and half year
- Secondary Outcome Measures
Name Time Method ILTimepoint: -